Consumer industry cross border M&A deals total $451.65m in Europe in December 2020
Total consumer industry cross border M&A deals worth $451.65m were announced in Europe in December 2020, led by Thrasio’s $269.69m acquisition of Maximo Fitness, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 90.8% over the previous month of $4.92bn and a drop of 86.9% when compared with the last 12-month average of $3.45bn.
Europe held a 36.42% share of the global consumer industry cross border M&A deal value that totalled $1.24bn in December 2020. With a 25.09% share and deals worth $311.13m, the UK was the top country in Europe’s cross border M&A deal value across consumer industry.
In terms of cross border M&A deal activity, Europe recorded 21 deals during December 2020, marking an increase of 23.53% over the previous month and a drop of 4.55% over the 12-month average. The UK recorded five deals during the month.
Europe consumer industry cross border M&A deals in December 2020: Top deals
The top five consumer industry cross border M&A deals accounted for 99.9% of the overall value during December 2020.
The combined value of the top five consumer cross border deals stood at $451.16m, against the overall value of $451.65m recorded for the month.
The top five consumer industry cross border M&A deals of December 2020 tracked by GlobalData were:
Thematic Reports
Are you worried about the pace of innovation in your industry?
GlobalData's TMT Themes 2021 Report tells you everything you need to know about disruptive tech themes and which companies are best placed to help you digitally transform your business.
Find out more1) Thrasio’s $269.69m acquisition of Maximo Fitness
2) The $86.5m acquisition of Passoa by Lucas Bols
3) Pollard Banknote’s $44.22m acquisition of Next Generation Lotteries
4) The $41.44m asset transaction with Sportech by BetMakers
5) Vision Healthcare’s acquisition of NaturaMed Pharma for $9.32m.
Verdict deals analysis methodology
This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.
Up Next
- Lost Password Back ⟶
- Login
- Register